The FDA says the recalled vials were shipped across the US and their sterility can't be guaranteed. Check the full notice for which products are affected.
Recap by typeshit. Post by Facebook on Facebook.
Bikman argues the facial change reflects rapid weight loss in general and suggests using the drug as a short-term aid for carb cravings. His view, not settled fact.
A clip from CNN's Body Language where two doctors point to common missteps they say lead to side effects on GLP-1 drugs. The full episode is on CNN.
An NYU obesity doctor outlines what people considering Ozempic or similar drugs should watch for. It is a general explainer for anyone weighing the shots.
15:57
A video on Chinese supply behind the peptide trend and the open question of what is actually in the vials people buy.
She points out that some of the weight lost on Ozempic, Wegovy or Mounjaro can be muscle, and argues this matters more in midlife. It's general advice, not new research.
Diabetologia highlights a study of the new oral GLP-1 receptor agonist, which the journal says showed encouraging efficacy and safety results.
Loading…